LONDON--(BUSINESS WIRE)--The intraosseous infusion devices market is poised to grow by USD 96.40 million during 2020-2024 progressing at a CAGR of over 4% during the forecast period. For a More ...
report provides actionable intelligence on factors that have been driving demand; key trends that are impacting the market; challenges that affect the market dynamics along with the market size, a ...
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Intraosseous cannulation is an accepted means to achieve vascular access when peripheral venous access is not available. It is common practice to flush the intraosseous cannula with saline prior to ...
With hospitals around the nation facing unprecedented financial burden related to COVID-19, and more people becoming uninsured, it’s critical for healthcare leaders to identify sources of revenue and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results